test-2 - Physician's Channel - Mount Sinai New York

Skip to main content

Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.

Refer a Patient Online

Or call 212-241-4983

View New Content

Featured Content

Mount Sinai Study: Controlling Heart Rhythm Before m-TEER Improves Outcomes

Mount Sinai Study: Controlling Heart Rhythm Before m-TEER Improves Outcomes

Mount Sinai Fuster Heart Hospital Awarded Transcatheter Valve Certification by American College of Cardiology for Second Time in a Row

Mount Sinai Fuster Heart Hospital Awarded Transcatheter Valve Certification by American College of Cardiology for Second Time in a Row

Mount Sinai Fuster Heart Hospital 2024

Mount Sinai Fuster Heart Hospital 2024

Transcatheter Mitral Valve Repair in Heart Failure Patients Significantly Improves Survival, Breakthrough Study Finds

Transcatheter Mitral Valve Repair in Heart Failure Patients Significantly Improves Survival, Breakthrough Study Finds

New Content |view more

Mount Sinai Neurosurgeon Leads Development of First CNS Guidelines for Treating Functioning Pituitary Adenomas

Mount Sinai Neurosurgeon Leads Development of First CNS Guidelines for Treating Functioning Pituitary Adenomas

The Congress of Neurological Surgeons (CNS) has released its first comprehensive, evidence-based guidelines for the care of adults with functioning pituitary adenomas (FPAs), a common yet complex condition.

Study Finds That an SGLT Inhibitor Is the First of Its Kind to Significantly Reduce Heart Attacks and Strokes

Study Finds That an SGLT Inhibitor Is the First of Its Kind to Significantly Reduce Heart Attacks and Strokes

Sotagliflozin, a drug approved by the FDA to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients.

Researchers Identify Molecular Glues That Protect Beta Cells From Glucolipotoxicity

Researchers Identify Molecular Glues That Protect Beta Cells From Glucolipotoxicity

The findings, by a Mount Sinai team in collaboration with European researchers, suggest a new strategy for preserving beta cell function in diabetes.

SGLT2 Inhibitor Empagliflozin Treatment Stabilizes Kidney Function in Patients Who Have Had a Heart Attack

SGLT2 Inhibitor Empagliflozin Treatment Stabilizes Kidney Function in Patients Who Have Had a Heart Attack

Mount Sinai-led study demonstrates kidney benefits of drug used in diabetes and heart failure

Mount Sinai Endocrinology Fellowship, the Largest in the U.S., Offers World-Leading Clinical and Research Training

Mount Sinai Endocrinology Fellowship, the Largest in the U.S., Offers World-Leading Clinical and Research Training

The fellows are treating complex conditions in the large population that the Mount Sinai Health System serves, and working closely with renowned experts in the field.

Mount Sinai Researchers Identify Molecular Glues That Protect Insulin-Producing Cells From Damage Related to Diabetes

Mount Sinai Researchers Identify Molecular Glues That Protect Insulin-Producing Cells From Damage Related to Diabetes

Findings could improve long-term outcomes for patients

Endocrinology, Diabetes and Bone Disease 2025

Endocrinology, Diabetes and Bone Disease 2025

The Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai is dedicated to advancing the understanding and treatment of diabetes, obesity, conditions affecting ...

Message From the Chief

Message From the Chief

The faculty in the Division of Endocrinology, Diabetes and Bone Disease continue to drive advances in translational research and clinical care.

Mount Sinai Lab Paves the Way for a New Era of Therapeutic Solutions for Thyroid Disease

Mount Sinai Lab Paves the Way for a New Era of Therapeutic Solutions for Thyroid Disease

With the publication of two 2024 studies, the Mount Sinai team led by Terry F. Davies, MD, continued to expand understanding of the physiologic mechanisms of Graves’ disease, as well as of thyroid eye disease, which about a third of people ...

Studies on Transgender Hormone Therapy Provide New Insights for Endocrinologists

Studies on Transgender Hormone Therapy Provide New Insights for Endocrinologists

Two 2024 studies from Mount Sinai—one on the risk of venous thromboembolism in transgender people and the other on understanding the effects of estrogen dose and route of administration on serum levels—provide vital information and insights ...

Review Highlights Endocrinologists’ Crucial Role in Diagnosing and Treating Adrenocortical Carcinoma

Review Highlights Endocrinologists’ Crucial Role in Diagnosing and Treating Adrenocortical Carcinoma

A case review by a team at the Icahn School of Medicine at Mount Sinai highlighted the crucial role of endocrinologists in the assessment and management of patients with adrenocortical carcinoma, a rare and aggressive form of cancer.

With Expanded Research, Mount Sinai Teams Aim to Support More Patients With Diabetes Technology

With Expanded Research, Mount Sinai Teams Aim to Support More Patients With Diabetes Technology

Carol J. Levy, MD, and teams at the Mount Sinai Diabetes Center are working to broaden the reach of diabetes technology to more people who could benefit from it, including pregnant women with type 1 diabetes and people with type 2 diabetes ...